BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21176400)

  • 1. Mesoangioblasts from facioscapulohumeral muscular dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior.
    Morosetti R; Gidaro T; Broccolini A; Gliubizzi C; Sancricca C; Tonali PA; Ricci E; Mirabella M
    Cell Transplant; 2011; 20(8):1299-313. PubMed ID: 21176400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies.
    Morosetti R; Mirabella M; Gliubizzi C; Broccolini A; Sancricca C; Pescatori M; Gidaro T; Tasca G; Frusciante R; Tonali PA; Cossu G; Ricci E
    Stem Cells; 2007 Dec; 25(12):3173-82. PubMed ID: 17761758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients.
    Vilquin JT; Marolleau JP; Sacconi S; Garcin I; Lacassagne MN; Robert I; Ternaux B; Bouazza B; Larghero J; Desnuelle C
    Gene Ther; 2005 Nov; 12(22):1651-62. PubMed ID: 15973444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The possible place of autologus cell therapy in facioscapulohumeral muscular dystrophy].
    Desnuelle C; Sacconi S; Marolleau JP; Larghero J; Vilquin JT
    Bull Acad Natl Med; 2005 Apr; 189(4):697-713; discussion 713-4. PubMed ID: 16245686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy.
    Macaione V; Aguennouz M; Rodolico C; Mazzeo A; Patti A; Cannistraci E; Colantone L; Di Giorgio RM; De Luca G; Vita G
    Acta Neurol Scand; 2007 Feb; 115(2):115-21. PubMed ID: 17212615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.
    Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A
    Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
    Winokur ST; Chen YW; Masny PS; Martin JH; Ehmsen JT; Tapscott SJ; van der Maarel SM; Hayashi Y; Flanigan KM
    Hum Mol Genet; 2003 Nov; 12(22):2895-907. PubMed ID: 14519683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis.
    Morosetti R; Gliubizzi C; Sancricca C; Broccolini A; Gidaro T; Lucchini M; Mirabella M
    Am J Pathol; 2012 Apr; 180(4):1603-13. PubMed ID: 22314077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal vascular disease and the pathogenesis of facioscapulohumeral muscular dystrophy. A signalling message from Wnt?
    Fitzsimons RB
    Neuromuscul Disord; 2011 Apr; 21(4):263-71. PubMed ID: 21377364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity.
    Banerji CRS; Henderson D; Tawil RN; Zammit PS
    Hum Mol Genet; 2020 Sep; 29(16):2746-2760. PubMed ID: 32744322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
    Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
    Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplanted mesoangioblasts require macrophage IL-10 for survival in a mouse model of muscle injury.
    Bosurgi L; Corna G; Vezzoli M; Touvier T; Cossu G; Manfredi AA; Brunelli S; Rovere-Querini P
    J Immunol; 2012 Jun; 188(12):6267-77. PubMed ID: 22573810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism.
    Kan HE; Klomp DW; Wohlgemuth M; van Loosbroek-Wagemans I; van Engelen BG; Padberg GW; Heerschap A
    NMR Biomed; 2010 Jul; 23(6):563-8. PubMed ID: 20175146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
    Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
    Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction.
    Turki A; Hayot M; Carnac G; Pillard F; Passerieux E; Bommart S; Raynaud de Mauverger E; Hugon G; Pincemail J; Pietri S; Lambert K; Belayew A; Vassetzky Y; Juntas Morales R; Mercier J; Laoudj-Chenivesse D
    Free Radic Biol Med; 2012 Sep; 53(5):1068-79. PubMed ID: 22796148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion-independent expression of functional ACh receptors in mouse mesoangioblast stem cells contacting muscle cells.
    Grassi F; Pagani F; Spinelli G; De Angelis L; Cossu G; Eusebi F
    J Physiol; 2004 Oct; 560(Pt 2):479-89. PubMed ID: 15319417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy patients.
    Di Pietro L; Giacalone F; Ragozzino E; Saccone V; Tiberio F; De Bardi M; Picozza M; Borsellino G; Lattanzi W; Guadagni E; Bortolani S; Tasca G; Ricci E; Parolini O
    Cell Death Dis; 2022 Sep; 13(9):793. PubMed ID: 36114172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane.
    De Bari C; Dell'Accio F; Vandenabeele F; Vermeesch JR; Raymackers JM; Luyten FP
    J Cell Biol; 2003 Mar; 160(6):909-18. PubMed ID: 12629053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways.
    Lolmede K; Campana L; Vezzoli M; Bosurgi L; Tonlorenzi R; Clementi E; Bianchi ME; Cossu G; Manfredi AA; Brunelli S; Rovere-Querini P
    J Leukoc Biol; 2009 May; 85(5):779-87. PubMed ID: 19197071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.